Skip to main content

Peer Review reports

From: Risk comparison of adverse reactions between gemcitabine monotherapy and gemcitabine combined with albumin-bound paclitaxel in pancreatic cancer: insights from the FDA Adverse Event Reporting System (FAERS) database

Original Submission
21 Nov 2024 Submitted Original manuscript
19 Dec 2024 Reviewed Reviewer Report
2 Jan 2025 Reviewed Reviewer Report
5 Feb 2025 Author responded Author comments - Zhongjun Wu
Resubmission - Version 2
5 Feb 2025 Submitted Manuscript version 2
6 Feb 2025 Author responded Author comments - Zhongjun Wu
Resubmission - Version 3
6 Feb 2025 Submitted Manuscript version 3
6 Feb 2025 Reviewed Reviewer Report
17 Feb 2025 Author responded Author comments - Zhongjun Wu
Resubmission - Version 4
17 Feb 2025 Submitted Manuscript version 4
26 Feb 2025 Reviewed Reviewer Report
Resubmission - Version 5
Submitted Manuscript version 5
Publishing
27 Feb 2025 Editorially accepted
19 Mar 2025 Article published 10.1186/s40360-025-00884-5

You can find further information about peer review here.

Back to article page